12th Annual Clinical Trials in Oncology Europe 2025

26 - 27

November

2025
  • Munich, Germany
  • Free
  • Why attend?
  • 2024 Agenda
  • 2024 Speakers
  • Plan Your Visit
  • Event Gallery
  • 2024 Sponsors
  • Media Centre
  • Why partner?
  • Contact Us
close

2024 Sponsors Included:

Back

Company Information

Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of ground-breaking technological innovation across more than 35,000 trials and 10 million patients, Medidata offers industry-leading expertise, analytics-powered insights, and the largest patient-level historical clinical trial data set in the world. More than 1 million registered users across approximately 2,300 customers trust Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand (Euronext Paris: FR0014003TT8, DSY.PA), Medidata is headquartered in New York City and has been recognized as a Leader by Everest Group and IDC. Discover more at www.medidata.com and follow us @Medidata.

Company Website

To learn more, please visit our website - https://www.medidata.com

Next Sponsor
Back

Company Information

ARENSIA Exploratory Medicine, a German-based company, is a leader in “first-in-patient” Phase IB and II/Proof-of-Concept clinical trials across a wide range of disease areas. With 14 proprietary research clinics and cutting-edge Phase I infrastructure, ARENSIA accelerates the early detection of efficacy signals for new therapies at an unparalleled speed. Its streamlined, highly efficient approach reduces patient recruitment time and costs by over 50% compared to conventional trial sites, which are often overcrowded and understaffed. This exceptional performance has resulted in a 93% repeat business rate and robust growth through collaborations with top pharmaceutical companies, biotechs, and global CROs. Headquartered in Düsseldorf, ARENSIA operates with a team of 600 professionals across 8 countries.

Company Website

To learn more, please visit our website - http://www.arensia-em.com/

Next Sponsor
Back

Company Information

SGS is a leading life sciences CRO providing clinical research and bioanalytical testing with a specific focus on early stage development and biometrics. Delivering solutions in Europe and in Americas, SGS offers clinical trial (Phase I to IV) services encompassing full early phase drug development consultancy, clinical project management and monitoring, biometrics, PK/PD modeling & simulation and regulatory & medical affairs services. SGS has its own clinical unit in Belgium including a viral challenge testing facility and two phase I patients units based in Belgium and Hungary.

SGS has a wealth of expertise in FIH studies, viral challenge testing, biosimilars and complex PK/PD studies with a high therapeutic focus in Infectious Diseases, Vaccines, and Respiratory.

Company Website

To learn more, please visit our website - http://www.sgs.com/en/life-sciences/clinical-research-services

Next Sponsor
Back

Company Information

Simply sourcing comparators – we offer a unique blend of small company flexibility and speed, backed with the large-scale buying power of the Orifarm Group, which is one of the largest pharmaceutical suppliers in Europe. With over €1.4B products sold in 2021 and more than 4,000 unique product lines sourced on a monthly basis, we have unparalleled access to “out of market” and manufacturer direct buying capability, both in the US and Europe.

Company website: www.Orifarm-CTS.com

Company Website

To learn more, please visit our website - www.Orifarm-CTS.com

Next Sponsor
Back

Company Information

Syneos Health (Nasdaq:SYNH*) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together, we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to lifeTM visit SyneosHealth.com. 

Company Website

To learn more, please visit our website - www.SyneosHealth.com

Next Sponsor
Back

Company Information

Scout empowers the life sciences industry with people-first solutions: Scout Meetings, Scout Clinical, and Scout Academy. We specialize in face-to-face, virtual, and hybrid clinical meeting planning, patient payment, travel, and logistics support, and virtual collaboration and education. Since 1995, we have been a trusted partner excelling in customer service, regulatory compliance, and project delivery for leading pharmaceutical and biotechnology companies. Our deep understanding of international regulations and adaptable network of resources is built on operational experience in 109 countries. With white-glove attention to detail and a customizable, comprehensive range of services, Scout makes the complex easier. Learn more at scoutclinical.com.

Next Sponsor
Back

Company Information

Science4Tech is a dynamic scaleup dedicated to advancing clinical trials through innovative technology and rigorous data management. Our cutting-edge AI solutions empower life science companies to streamline drug development, reducing time and costs significantly. We prioritize the highest scientific standards and unwavering regulatory compliance across all phases of clinical trials.

Company Website

To learn more, please visit our website - https://s4t.health/

Next Sponsor
Back

Company Information

Worldwide is changing how the world experiences CROs – in the best possible way. From early phase, bioanalytical sciences, late phase, post-approval and real-world evidence, Worldwide Clinical Trials provides full-service drug development services for central nervous system, cardiovascular, metabolic, general medicine, oncology and rare disease therapies.

Company Website

To learn more, please visit our website - https://www.worldwide.com

Next Sponsor
Back

Company Information

Suvoda is a global clinical trial technology company specializing in complex, life-sustaining studies in therapeutic areas like oncology, central nervous system (CNS), and rare disease. Founded in 2013 by experts in eClinical technologies, Suvoda empowers clinical trial professionals to manage the most urgent moments in the most urgent trials through advanced software solutions delivered on a single platform. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company’s Net Promoter Score (NPS) consistently exceeds the technology industry average, contributing to the company being selected by trial sponsors and CROs to support more than 1,000 trials across 80 countries.

Company Website

To learn more, please visit our website - https://www.suvoda.com/

Next Sponsor
Back

Company Information

Fortrea is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas. Our talented and diverse team of more than 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally.

Company Website

To learn more, please visit our website - https://www.fortrea.com/

Next Sponsor
Back

Company Information

Medicover Integrated Clinical Services is a unique clinical research organization with 25 years of experience.

We offer Patient Recruitment services through our own Clinical Research Network in Central and Eastern Europe with comprehensive Global Central Lab Services and access to over 8,000 tests from routine to advanced diagnostics including genetics, biomarkers, PK and PD, and PBMC isolation in more than 120 laboratories in Europe and India.

Company Website

To learn more, please visit our website - https://medicover-mics.com/

Next Sponsor
Back

Company Information

Greenphire is the industry leader of clinical payment technology, designed to improve the way research professionals work. We leverage our proprietary payments platform and workflow automation to help clients improve operational efficiency, reduce costs, mitigate regulatory risks, improve the patient and site experience and produce quantifiable results that improve clinical operations and strategic planning.

Company Website

To learn more, please visit our website - http://greenphire.com/

Next Sponsor
Back

Company Information

Myonex provides tailored services and solutions to advance medicine through clinical to commercial stages with tailored drug sourcing and ancillary supply, to packaging, labeling, and distribution. With ten global locations, we offer flexible, efficient, and cost-effective support for clients across the pharmaceutical and biotech sectors.

 

Company Website

To learn more, please visit our website - www.myonex.com

Next Sponsor
Back

Company Information

LabConnect provides global central laboratory services including routine and esoteric lab testing, kit building, sample management, biostorage and scientific support services for our biopharmaceutical clients. LabConnect’s unique combination of state-of-the-art technology, world-class laboratories, easy access to emerging markets and extensive specialized testing expertise means the drug development industry can rely on a single provider for all of their central lab needs.

Company Website

To learn more, please visit our website - http://www.labconnectllc.com/

Next Sponsor
Back

Company Information

PSI is a privately-owned, full-service contract research organization (CRO), operating globally. PSI’s reputation on the market place is that of a no-nonsense CRO, capable of saving pharmaceutical sponsors millions of development dollars by consistently meeting clinical trial timelines. PSI’s global reach supports the operations of clinical trials across multiple countries.

Company Website

To learn more, please visit our website - http://www.psi-cro.com/

Next Sponsor
Back

Company Website

To learn more, please visit our website - www.evidentiq.com

Next Sponsor
Back

Company Information

Zanteris offers Clinical Operations, Project Management resourcing, and Consulting services within the Pharmaceutical industry, we use our deep expertise to identify quality solutions that help you execute your clinical study on time. Utilizing our experience of managing clinical trials across a range of medical conditions, we apply a tailored customer experience backed by strong data. Dedicated to optimized studies and risk management, our goal is to support your race in drug development.

Company Website

To learn more, please visit our website - www.zanteris.com

Next Sponsor
Back

Company Information

Endpoint Clinical is an interactive response technology (IRT) solutions provider that supports the life sciences industry. Our innovative, high-quality randomization and clinical trial management technologies are backed by over a decade of award-winning experience and expertise. Endpoint is headquartered in Wakefield, MA, with offices across the US, EU, and Asia.

Company Website

To learn more, please visit our website - http://www.endpointclinical.com/

Next Sponsor
Back

Company Information

Signant Health provides solutions that simplify every step of the patient journey to make it easier for people to participate in, and for sites and study teams to run, clinical trials. Signant unites eCOA, eConsent, Patient Engagement, IRT, Clinical Supplies and Endpoint Quality into the industry’s most comprehensive patient-centric suite – an evolution built on more than 20 years of proven clinical research technology. Our intense focus on the patient experience, deep therapeutic area expertise and global operational scale enable hundreds of sponsors and CROs (including all Top 20 pharma) to extend the reach of drug development, expand patient opportunities and improve data quality – helping them bring life-changing therapies to our families and communities around the world.

Company Website

To learn more, please visit our website - www.signanthealth

Next Sponsor
Back

Company Website

To learn more, please visit our website - mediantechnologies.com

Next Sponsor

    Why attend?

    Arena International are delighted to announce 11th Annual Clinical Trials in Oncology Europe will be returning to Munich on 26-27 November 2025!

    The programme will, through a variety of interactive session formats, offer insight on promoting successful collaboration between the clinical trials community and once again offer attendees practical take-aways that they can apply to their own studies.

    Our Munich event will cover different perspectives of operational challenges meaning there truly is something for everyone!

    Don’t miss out; join us in Munich on 26-27 November 2025!! We can’t wait to see you there!

    WHAT TO EXPECT FOR 2025?

    At the Clinical Operations in Oncology Trials Europe event, taking place on 25th-26th November in Munich, we are pleased to bring together the definitive group of executives responsible for clinical operations in oncology and enhancing the partnership with vendors. There will be expert guidance through a first class conference programme and numerous networking opportunities.

    150+

    ATTENDEES TO MEET EACH YEAR

    		20+

    EXHIBITORS TO MEET EACH YEAR

    		20+

    SPEAKERS
    150+

    ATTENDEES TO MEET EACH YEAR

    		20+

    EXHIBITORS TO MEET EACH YEAR
    20+

    SPEAKERS

    WHY ATTEND?

    NETWORK

    This is an exceptional networking opportunity for industry accelerators. Meet industry C-Suite and Director level executives to make valuable connections at this annual thought leadership platform.

    LEARN

    Join like-minded peers to hear new perspectives and case studies through presentations, panel discussions and interactive round tables

    ACTION

    The conference discusses the vital connections between process, tools and techniques to manage change. Update your knowledge to create new strategies enabling you to enact change.

    See What It's All About

    2024 Agenda

    • 3 Dec 2024
    • 4 Dec 2024
    Expand All

    8:15 AM

    Registration and refreshments

    8:50 AM

    Chairperson’s opening remarks

    9 AM

    Establishing an AI strategy for oncology clinical trials: what to consider

    • Reiterating basics of AI and its uses in pharma
    • Identification and prioritization of suitable AI and tools
    • Building a holistic AI strategy: incorporating tools, ethics and data privacy
    • Creating the roadmap: challenges and lessons learnt to overcome them

    Speakers

    Frank Richard
    Vice President Medical, Heidelberg Pharma

    9:30 AM

    Clinical research needs a moonshot: What patients can teach us about innovation

    In this captivating presentation, Alicia will share her experience as a three-time cancer survivor and what she’s learned about the state of clinical research from the patient perspective. Since her initial diagnosis to today, she’ll share how her journey changed the course of her career. Her focus on improving the patient experience and highlighting critical needs throughout the clinical trial ecosystem can help data management professionals find new ways to unlock value for all stakeholders.

    Alicia will share how her health information and clinical trial data are still siloed and why this erodes the patient experience for all.

    Without collaboration, true innovation is not possible. Alicia will inspire the audience to look for new ways to collaborate to bring efficiency and empathy to the solutions that support the industry.  That’s the essence of a moonshot - an industry wide collaboration that’s an ambitious venture to deliver profound results.

    • Understand how the patient perspective can help highlight ways to improve processes and solutions to deliver a best-in-class patient experience
    • Recognize the need for building a true collaborative framework to address key patient needs and how data management and solutions provide a crucial role in this work
    • Envision the future of data management as an industry leading innovation hub and a core function of patient centricity

    Speakers

    Alicia Staley
    VP Patient Engagement, Medidata Dassault Systemes

    10 AM

    From the 1930s to today: the evolution of clinical trial regulations

    This session explores the pivotal milestones in clinical trial regulation from the 1930s onward, highlighting key changes that shaped today’s standards in patient safety, ethical considerations, and scientific rigor. Participants will gain insights into how regulations evolved in response to historical events and scientific advancements, providing a comprehensive understanding of the frameworks that ensure ethical practices and patient protection in clinical trials today.

    • The early days: Establishing regulatory foundations following critical incidents in the 1930s and 1940s
    • Nuremberg Code (1947) and Declaration of Helsinki (1964): Milestones in ethical standards
    • FDA regulations and the Belmont Report (1979): Shaping patient protection in clinical trials
    • ICH-GCP guidelines (1996): Introducing a unified standard for international trials

    Speakers

    Cornelia Baumgartner
    Head of Clinical Operations, T-CURX

    10:30 AM

    Morning refreshments and networking

    11 AM

    Partnering with academia for paediatric oncology clinical development

    • Paediatric oncology trials pose unique challenges
    • International clinical trial networks have traditionally driven the clinical development of new agents for pediatric patients
    • Partnership opportunities for study protocol preparation and patient selection: the case for basket trials
    • Regulatory implications and the case for "fit-for-filing" studies
    • Examples of collaborative approaches

    Speakers

    Cesare Spadoni
    Founder & Chief Operating Officer, Oncoheroes Biosciences

    11:30 AM

    Why so slow? Insider insights from the clinic floor to speed up the conduct of proof-of-concept patient trials

    • Feasibility figures true to delivery
    • Regulatory dynamics for strategic advantages
    • Collaborate with patients and physicians to enhance access to innovative therapies
    • New study designs that accelerate development programs

    Speakers

    Dr. Claudia Hesselmann
    Founder & CEO, ARENSIA Exploratory Medicine

    12 PM

    Fireside Chat: Navigating complexities of managing radioligand therapy oncology trials

    • Site selection considerations specific to Radiopharmaceutical Therapy (RPT) clinical trials
    • A sponsor’s perspective of the technical knowledge and expertise required to deliver RPT studies
    • Country specific RPT clinical trial requirements and regulations
    • Challenges with just-in-time supply for RPT investigational products

    Speakers

    Liz Emmerson
    Director Clinical Operations, Blue Earth Therapeutics

    12:30 PM

    Lunch and networking

    1:30 PM

    Panel Discussion: Integrating imaging into oncology clinical trials

    • Selecting an imaging vendor
    • Decentralized clinical imaging
    • Multi specialist access to imaging
    • Electronic data transfer
    • Importance of patient data return

    Speakers

    Sarah Westall
    Solutions Specialist, Medidata
    Alicia Staley
    VP Patient Engagement, Medidata Dassault Systemes
    Justus Harris
    Patient Advocate
    Helen Johansen Blanco
    Chief Operating Officer, Node Pharma A/S

    2 PM

    Technology Spotlight: Unleashing the power of data and AI to transform clinical trials

    Hear from a representative at Science4Tech on how they are advancing access to numerous technological innovations, elevating the quality, rigor, and reliability of clinical research rooted in the scientific method.

     Science4Tech Representative

    2:15 PM

    Tailored trial designs for precise outcomes

    In this presentation Matt will discuss strategies to optimize the design and delivery of early phase oncology trials, including:

    • Dose optimisation and dose selection in early phase oncology trials
    • Adaptive designs
    • Accelerated titration for early cohorts
    • Backfill strategies
    • Biomarker analysis integration

    Speakers

    Matt Cooper
    Executive Director, Therapeutic Strategy Lead, Oncology, Worldwide Clinical Trials

    2:45 PM

    Fireside Chat: Considering requirements and challenges of cell therapy oncology trials as a small biotech

    • Creating strategies and operational processes
    • Addressing challenges and complexities of cell therapy oncology trials
    • Selecting fit for purpose service providers to assist

    Speakers

    Sarah Bischof
    Head of Clinical Development, invIOs

    3:15 PM

    Afternoon refreshments and networking

    3:45 PM

    Sharing digital patient centric initiatives to enhance patient engagement in clinical trials

    • Considering touchpoints of how and when we can digitally reach patients
    • Collating digital patient input to incorporate their voice
    • Highlighting challenges and benefits of digital patient engagement

    Speakers

    Dr. Nicolas Schneider
    Director Clinical Operations and Alliance Management, ITM Isotopen Technologien München

    4:15 PM

    FDA’s Project Optimus and Its Impact on Drug Development

    Project Optimus, an initiative led by the FDA’s Oncology Center of Excellence, is reshaping the landscape of oncology drug development by fundamentally altering the approach to dose optimization and dose selection. Traditionally, oncology drug trials focused on identifying the maximum tolerated dose (MTD) to ensure efficacy, often at the cost of increased toxicity. However, Project Optimus challenges this paradigm, advocating for a more nuanced approach where multiple doses are rigorously tested to find the optimal balance between efficacy, safety, and patient tolerability.

    The initiative’s impact extends across various stages of drug development, from preclinical studies to pivotal Phase III trials. By emphasizing early collaboration between drug developers and the FDA, Project Optimus aims to ensure that the chosen doses not only maximize therapeutic benefit but also minimize adverse effects, thereby enhancing the overall success rate of oncology therapies.

    However, this shift is not without its challenges. The need for larger, more complex trials and the incorporation of innovative trial designs, such as seamless Phase I/II studies and randomized dose-ranging trials, can increase the time and cost associated with drug development. Smaller biotech companies, in particular, may face difficulties adapting to these new requirements. Yet, the long-term benefits—more effective treatments with fewer side effects—promise to transform patient outcomes and set a new standard in oncology drug development.

    Introduction

    • Overview of Project Optimus and its origins within the FDA’s Oncology Center of Excellence.
    • The traditional approach to dose selection in oncology (MTD-focused) and its limitations.

    Key Objectives of Project Optimus

    • Reforming dose optimization to focus on efficacy, safety, and tolerability.
    • Encouraging early and ongoing collaboration between drug developers and the FDA.
    • Integrating patient-reported outcomes (PROs) into dose-finding studies to better assess tolerability.

    Impact on Early-Phase Drug Development

    • Changes in Phase I and Phase II trial designs, including the move away from 3+3 dose-escalation models.
    • The role of pharmacokinetic (PK) and pharmacodynamic (PD) data in dose selection.
    • Case studies highlighting the successful implementation of Project Optimus guidelines (e.g., Amgen’s Lumakras, GSK’s Blenrep).

    Challenges and Opportunities

    • Increased trial complexity, costs, and the need for larger patient populations.
    • Implications for smaller biotech companies and strategies to navigate these challenges.
    • Potential long-term benefits, including improved patient outcomes and reduced trial failure rates.

    The Future of Oncology Drug Development

    • How Project Optimus may influence global regulatory practices.
    • The evolving role of dose optimization in other therapeutic areas beyond oncology.
    • Predictions for the next decade of drug development under the Project Optimus framework.

    Conclusion

    • Recap of the transformative impact of Project Optimus on oncology drug development.
    • Final thoughts on how the industry can adapt to these changes to bring safer, more effective therapies to patients.

    Speakers

    Rob Berg
    VP Medical Management, Syneos Health

    4:45 PM

    Sharing a patient perspective of clinical trials and the journey to recovery

    Carol was diagnosed with Hodgkins Lymphoma in 2004 and her life and music career was all put on hold. She was repeatedly told that she would not survive, but now, in remission with a different blood type and new DNA, she is one of the most in-demand session musicians in the UK.

    Carol will discuss her decade-long fight with cancer, her experiences with failed treatments, transplants and clinical trials and how she has faced fear head on and beaten the odds.

    Speakers

    Carol Jarvis
    Patient Advocate

    5:30 PM

    Chairperson’s closing remarks

    END OF DAY 1 AND NETWORKING DRINKS

    8:30 AM

    Registration and Refreshments

    8:50 AM

    Chairperson’s opening remarks

    9 AM

    Speaker Hosted Roundtables

    Speaker Hosted Roundtables
    Interactive roundtable sessions offer a unique opportunity to come together with your peers to share best practice and develop solutions to critical challenges facing the industry.

    Hosted by industry experts and each focused on a single issue, roundtables are an exciting, interactive way to build your personal network and learn from the experience and expertise of others.

    Each roundtable session lasts for 30 minutes, and delegates may attend up to 2 roundtables.

    RT 1: Discussing AI strategies, benefits and challenges: experiences and future planning
    Frank Richard, Vice President Medical, Heidelberg Pharma

    RT 2: Collaborating between sponsor, CROs and sites effectively to increase efficiency
    Marta Perez-Noguera, Director Clinical Operations EU, Luzsana

    RT 3:Considering project plans in clinical trials: why are they so important?
    Cornelia Baumgartner, Head of Clinical Operations,  T-CURX

     

    Speakers

    Frank Richard
    Vice President Medical, Heidelberg Pharma
    Marta Perez-Noguera
    Director Clinical Operations EU, Luzsana
    Cornelia Baumgartner
    Head of Clinical Operations, T-CURX

    10 AM

    Morning refreshments and networking

    10:30 AM

    Panel Discussion: Negotiating vendor agreements: getting the right balance for both sponsor and service provider

    • Finding the right balance between the needs of sponsor company and vendor to ensure right fit
    • Negotiating contracts: getting the right deal
    • Dealing with change orders and managing the budget
    • Forging partnerships and relationships to enhance contract negotiations and communication

    Speakers

    Cesare Spadoni
    Founder & Chief Operating Officer, Oncoheroes Biosciences
    Dr. Claudia Hesselmann
    Founder & CEO, ARENSIA Exploratory Medicine
    Dr. Nicolas Schneider
    Director Clinical Operations and Alliance Management, ITM Isotopen Technologien München

    11:15 AM

    Respecting patient and site voices: Practical steps to streamline clinical technologies

    • Examine the oncology clinical trial journey from patient and site perspectives, identifying current stressors and opportunities to solve challenges
    • Dive in on specific practices and technologies that can remove friction from the trial experience for patients and reduce workloads for sites
    • Identify future innovation spaces to streamline the trial experience and how that can lead to better care for patients and better trial outcomes for sponsors

    Speakers

    Daniela Duffett
    Senior Solutions Consultant, Suvoda

    11:45 AM

    Evaluating projects starting from ideation by utilizing knowledge resources

    • Evaluating, predicting and understanding of the Innovator:
      • Product value, medical potential, product profile
      • Ongoing studies, IP intelligence
    • Defining the details of the generic development:
      • Competition level
      • Markets, generic pricing

    Speakers

    Bahadir Cakmak
    Director Early Portfolio & Pipeline, Sandoz

    12:15 PM

    Voice of sites: Solving the last mile

    • Review current challenges that have a direct impact on site engagement and performance
    • Exploration of practical solutions that will enable and elevate the voice of sites into clinical trial designs
    • Case studies and examples of how a collaborative approach with sites delivers insightful study design, greater confidence of patient recruitment and strong patient retention

    Speakers

    Constance Jung-Stach
    Head of EMEA Partnership Growth, Fortrea
    Amanda Nogueira
    Senior Medical Director Oncology, Fortrea

    12:45 PM

    Lunch, networking and Apple prize draw

    2:15 PM

    What is needed to build a major biotechnology/pharmaceutical company: an evaluation of the level of ambition and the possible underlying causes

    • Investing in the right people – early gap analysis
    • Financial strategy leading to success
    • Competitive Intelligence – market analysis & selection of indication
    • Common factors of management that succeed

    Speakers

    Helen Johansen Blanco
    Chief Operating Officer, Node Pharma A/S

    2:45 PM

    Optimizing oncology trial efficiency through adaptive design and real-time data

    • Geographic feasibility for country selection
    • Benchmarking timelines, trial costs and recruitment rates
    • DCT complications
    • Site selection process including e-feasibility questionnaires

    Speakers

    Ophelia Chan
    Senior Analyst, GlobalData

    3:15 PM

    Chairperson’s closing remarks and close of conference

    2024 Speakers

    Select a speaker to learn more

    Back
    Liz Emmerson
    Director Clinical Operations, Blue Earth Therapeutics

    Session Details:

    Fireside Chat: Navigating complexities of managing radioligand therapy oncology trials

    2024-12-03, 12:00 PM

    View In Agenda
    Next speaker
    Back
    Frank Richard
    Vice President Medical, Heidelberg Pharma

    Session Details:

    Establishing an AI strategy for oncology clinical trials: what to consider

    2024-12-03, 9:00 AM

    Session Details:

    Speaker Hosted Roundtables

    2024-12-04, 9:00 AM

    View In Agenda
    Next speaker
    Back
    Sarah Bischof
    Head of Clinical Development, invIOs

    Session Details:

    Fireside Chat: Considering requirements and challenges of cell therapy oncology trials as a small biotech

    2024-12-03, 2:45 PM

    View In Agenda
    Next speaker
    Back
    Sarah Westall
    Solutions Specialist, Medidata

    Session Details:

    Panel Discussion: Integrating imaging into oncology clinical trials

    2024-12-03, 1:30 PM

    View In Agenda
    Next speaker
    Back
    Cesare Spadoni
    Founder & Chief Operating Officer, Oncoheroes Biosciences

    Cesare is co-founder and Chief Operating Officer of Oncoheroes Biosciences Inc., a Boston-based biotech company focused on pediatric oncology drug development. Cesare has more than 20 years of experience in the drug development field, in both scientific and commercial roles. Previously, he held senior positions at AMRI, Aptuit Laurus, ThalesNano and Auxiliis. Cesare started his career as research scientist in a pharmaceutical company (Eisai, London) and in academia (Institute of Enzymology, Budapest).

    Following the death of his first daughter Laura to cancer, Cesare set up aPODD Foundation, a London-based charity focused on accelerating paediatric oncology drug development. As aPODD’s chairman he is actively involved on a pro-bono basis in drug repurposing projects, advocacy efforts and research collaborations.

    Cesare holds an MSc in Applied Molecular Biology and a PhD in Neurosciences from UCL, University of London, as well as an MBA from the Central European University, Budapest.

    Session Details:

    Panel Discussion: Negotiating vendor agreements: getting the right balance for both sponsor and service provider

    2024-12-04, 10:30 AM

    Session Details:

    Partnering with academia for paediatric oncology clinical development

    2024-12-03, 11:00 AM

    View In Agenda
    Next speaker
    Back
    Bahadir Cakmak
    Director Early Portfolio & Pipeline, Sandoz

    Session Details:

    Evaluating projects starting from ideation by utilizing knowledge resources

    2024-12-04, 11:45 AM

    View In Agenda
    Next speaker
    Back
    Carol Jarvis
    Patient Advocate

    ​Carol Jarvis was diagnosed with Hodgkins Lymphoma in 2004 - her life and music career was all put on hold.

    Little did she know then, but her fight with cancer would go on for over a decade with multiple failed treatments, transplants and clinical trials and she was repeatedly told that she would not survive.

    But now, in remission with a different blood type and new DNA, she has given talks across the globe, from Boston to Singapore, Brazil to Croatia and Denmark to Mexico, about facing fear head-on, setting new statistics and beating the odds.

    Session Details:

    Sharing a patient perspective of clinical trials and the journey to recovery

    2024-12-03, 4:45 PM

    View In Agenda
    Next speaker
    Back
    Ophelia Chan
    Senior Analyst, GlobalData

    Session Details:

    Optimizing oncology trial efficiency through adaptive design and real-time data

    2024-12-04, 2:45 PM

    View In Agenda
    Next speaker
    Back
    ​​Priya Ravisekara
    Senior Analyst, GlobalData

    Priya Ravisekara, MSc,is a senior analyst at GlobalData in London, UK, where her primary responsibilities include producing analytical reports, improving and maintaining database functionality through quality assurance testing, updating and monitoring Global Data’s Clinical Trials Intelligence Database, and answering queries directly from clients. Priya holds a Masters in Clinical Drug Development from Barts and The London School of Medicine and Dentistry, and a Bachelor of Science in Biochemistry from Brunel University, London.​

    Next speaker
    Back
    Dr. Nicolas Schneider
    Director Clinical Operations and Alliance Management, ITM Isotopen Technologien München

    Session Details:

    Sharing digital patient centric initiatives to enhance patient engagement in clinical trials

    2024-12-03, 3:45 PM

    Session Details:

    Panel Discussion: Negotiating vendor agreements: getting the right balance for both sponsor and service provider

    2024-12-04, 10:30 AM

    View In Agenda
    Next speaker
    Back
    Dr. Claudia Hesselmann
    Founder & CEO, ARENSIA Exploratory Medicine

    Dr. Claudia Hesselmann, a chemist by training, with a PhD in molecular biology. Claudia has twenty years of expertise in the early phases of drug development. Her experience includes co-founding and holding management positions in various CROs. Her extensive background and social acumen, along with her first-hand knowledge of the industry, led Claudia to co-found ARENSIA Exploratory Medicine in Düsseldorf, Germany. Her primary aim is the contribution of innovative approaches to bring about substantial acceleration to the drug development process and enable more agile patient access to novel therapeutics.

     

    Session Details:

    Why so slow? Insider insights from the clinic floor to speed up the conduct of proof-of-concept patient trials

    2024-12-03, 11:30 AM

    Session Details:

    Panel Discussion: Negotiating vendor agreements: getting the right balance for both sponsor and service provider

    2024-12-04, 10:30 AM

    View In Agenda
    Next speaker
    Back
    Alicia Staley
    VP Patient Engagement, Medidata Dassault Systemes

    Alicia Staley serves as vice president of Patient Engagement at Medidata. She oversees the Patient Insights Program and the Patient Insights Board. She works to infuse the patient perspective throughout the product development lifecycle and help engage patients in novel ways. She created Patient Centricity by Design (PCbD) in 2018 as a way to provide structure and governance for developing patient-centric technical solutions.

    Alicia has over 20 years of experience in software design and information systems management.  She is also a three-time cancer survivor, first diagnosed with Hodgkin’s disease as a sophomore during college. With an extensive network of patient advocates and non-profit organizations, she collaborates with a wide range of stakeholders to help improve processes and policies that impact cancer care.

    As a champion of patient advocacy and engagement, she understands the critical issues facing patients seeking to engage in clinical research.

    Session Details:

    Panel Discussion: Integrating imaging into oncology clinical trials

    2024-12-03, 1:30 PM

    Session Details:

    Clinical research needs a moonshot: What patients can teach us about innovation

    2024-12-03, 9:30 AM

    View In Agenda
    Next speaker
    Back
    Daniela Duffett
    Senior Solutions Consultant, Suvoda

    Daniela Duffett is the European Solutions Consultant at Suvoda, based out of our Barcelona office. She consults with clients and prospects, delivering presentations and demonstrations, while acting as a Subject Matter Expert on Suvoda’s solutions. She started at Suvoda five years ago on the Project Management side of our Services Delivery organization, so can impart her hands-on delivery experience & knowledge.

     

    Session Details:

    Respecting patient and site voices: Practical steps to streamline clinical technologies

    2024-12-04, 11:15 AM

    View In Agenda
    Next speaker
    Back
    Matt Cooper
    Executive Director, Therapeutic Strategy Lead, Oncology, Worldwide Clinical Trials

    Matt Cooper is the Executive Director, Therapeutic Strategy Lead, Oncology and has 25 years of experience in the life science industry conducting clinical trials across all phases. His experience spans roles at sponsors, sites, and the NHS, and he has extensive experience in site management and expanded use of oncology therapies. He is passionate about building effective relationships between industry stakeholders to drive innovation and patient access.

    Session Details:

    Tailored trial designs for precise outcomes

    2024-12-03, 2:15 PM

    View In Agenda
    Next speaker
    Back
    Cornelia Baumgartner
    Head of Clinical Operations, T-CURX

    Session Details:

    From the 1930s to today: the evolution of clinical trial regulations

    2024-12-03, 10:00 AM

    Session Details:

    Speaker Hosted Roundtables

    2024-12-04, 9:00 AM

    View In Agenda
    Next speaker
    Back
    Marta Perez-Noguera
    Director Clinical Operations EU, Luzsana

    Session Details:

    Speaker Hosted Roundtables

    2024-12-04, 9:00 AM

    View In Agenda
    Next speaker
    Back
    Helen Johansen Blanco
    Chief Operating Officer, Node Pharma A/S

    Helén Johansen Blanco has 24 years of clinical development experience, managing Phase I to III clinical trials leading to the successful launch of several oncology products, as Revlimid, Xofigo and a Herceptin biosimilar. She has experience in project management and financial oversight of large global clinical trials conducted in all continents of the world, mainly within oncology, but also therapeutic areas as cardiovascular and gastrointestinal. Mrs. Blanco has previously worked for large international pharma companies such as AstraZeneca and Mylan, as well as small, medium to large sized biotechnology companies as Nordic Nanovector, Oncoinvent, Cantargia, Cytovation and Celgene. Currently she holds a position as Chief Operating Officer at Node Pharma AS, a small medium sized Norwegian biotech company. She holds a Diploma Engineer/MSc degree in Biophysics and medical technology and a MBA.

    Session Details:

    Panel Discussion: Integrating imaging into oncology clinical trials

    2024-12-03, 1:30 PM

    Session Details:

    What is needed to build a major biotechnology/pharmaceutical company: an evaluation of the level of ambition and the possible underlying causes

    2024-12-04, 2:15 PM

    View In Agenda
    Next speaker
    Back
    Justus Harris
    Patient Advocate

    Justus Harris is a designer, healthcare strategist, and artist with two decades of lived type 1 diabetes experience. His expertise lies at the intersection of data visualization and narratives, enabling him to communicate personal and public health insights effectively. His creations encompass the transformation of medical data into 3D-printed objects, augmented reality experiences, and intuitive 2D designs. Features include the Kennedy Center as a Citizen Artist Fellow, Stanford Medicine X as an ePatient Scholar, and TEDx as a speaker.

    His clients range from data-driven health companies such as Teledoc (formerly Livongo), One Drop, and Medidata as a Patient Insights Board member.

    As an advocate, Justus is committed to helping improve the lives of patients in the ongoing COVID pandemic, patients without access to affordable treatments, and LGBTQIA+ individuals in the EU and United States.

    Session Details:

    Panel Discussion: Integrating imaging into oncology clinical trials

    2024-12-03, 1:30 PM

    View In Agenda
    Next speaker
    Back
    Constance Jung-Stach
    Head of EMEA Partnership Growth, Fortrea

    Session Details:

    Voice of sites: Solving the last mile

    2024-12-04, 12:15 PM

    View In Agenda
    Next speaker
    Back
    Rob Berg
    VP Medical Management, Syneos Health

    Session Details:

    FDA’s Project Optimus and Its Impact on Drug Development

    2024-12-03, 4:15 PM

    View In Agenda
    Next speaker
    Back
    Amanda Nogueira
    Senior Medical Director Oncology, Fortrea

    Session Details:

    Voice of sites: Solving the last mile

    2024-12-04, 12:15 PM

    View In Agenda
    Next speaker

    Plan Your Visit

    Venue

    Munich, Germany

    Accommodation

    Arena International Events Group “(Arena”) is aware of numerous third party agencies which are contacting Arena’s customers and purporting to have access to hotel room bookings and events attendee lists. For the avoidance of doubt, Arena will only share attendee lists with carefully selected third party partners for event registration purposes. Whilst Arena International Events Group pursues third party agencies for their potentially illicit activity, Arena encourages you to be cautious in engaging with such third party agencies and Arena shall not accept any responsibility for any losses incurred by you should you choose to engage with third parties that have no affiliation to Arena International Events Group.. Arena International Events Group “(Arena”) is aware of numerous third party agencies which are contacting Arena’s customers and purporting to have access to hotel room bookings and events attendee lists. It is unclear whether the agencies in question are in possession of such information, or whether they intend to scam unsuspecting customers. Whilst Arena International Events Group pursues such third party companies for their potentially illicit activity, Arena encourages you to be cautious in engaging with such third party agencies and Arena shall not accept any responsibility for any losses incurred by you should you choose to engage with third parties that have no affiliation to Arena International Events Group.

    2024 Sponsors

    Select a sponsor to learn more

    FEATURED SPONSOR

    SESSION SPONSOR

    Technology showcase sponsor

    EXHIBITOR

    CO-Sponsors

    Why partner?

     

    Contact us to become a partner

    Partnership Opportunities

    We work with you to design a bespoke package to meet your business needs, where you could:

    • Demonstrate your expertise on the agenda – have the attention of the entire audience. For greatest impact, why not position your talk before a networking break and immediately conduct follow up conversations with highly engaged attendees
    • Showcase your business and its services at an exhibition booth, which provides a perfect meeting place for prospective new clients
      Present the value proposition of your offering over your competitors, in front of an audience of active, engaged potential customers
    • Speak with key decision makers as part of our intimate, interactive roundtable style workshop sessions with over 8 hours allowed for networking

    Event reach

    • 150+ attendees each year
    • 80% attendees C-suite level

     

    Take a look at our current sponsors

    Media Centre

    MEDIA PARTNERS

    Become A Media Partner

    Enquiry

    Contact Us

    SPONSORSHIP ENQUIRIES

    Conor Taylor

    +44 (0)20 7936 6870

    SPEAKING OPPORTUNITIES

    Maya Hudson

    Deputy Head of Production

    +44 204540 7766

    MARKETING ENQUIRIES

    Moona Popal

    Marketing Manager

    DELEGATE ENQUIRIES

    Sunny Saikia

    VIP Delegate Manager

    SPONSORSHIP ENQUIRIES

    To enquire about sponsorship opportunities for the conference, please contact:

    Conor Taylor

     


    +44 (0)20 7936 6870

    SPEAKER ENQUIRES

    The program for the event is underway. Please get in touch with the program director if you would like to be part of the program

    Maya Hudson

    Deputy Head of Production


    +44 204540 7766